AI assistant
Sending…
IMMUNIC, INC. — Director's Dealing 2021
May 12, 2021
10196_dirs_2021-05-12_38c2fe56-4f9f-4b2b-863c-450790abd9a6.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IMMUNIC, INC. (IMUX)
CIK: 0001280776
Period of Report: 2021-05-12
Reporting Person: Nash Duane (Director, Executive Chairman)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-05-12 | Common Stock | P | 4000 | $12.75 | Acquired | 14032 | Direct |
More from IMMUNIC, INC.
Regulatory Filings
2026
May 28
Board/Management Information
2026
May 27
Board/Management Information
2026
May 19
Regulatory Filings
2026
May 13
Interim / Quarterly Report
2026
May 13
Earnings Release
2026
May 13
Regulatory Filings
2026
Apr 30
Regulatory Filings
2026
Apr 28
Board/Management Information
2026
Apr 28
Regulatory Filings
2026
Apr 23